Invention Grant
- Patent Title: Anti-dengue virus NS1 protein monoclonal antibodies
-
Application No.: US15429756Application Date: 2017-02-10
-
Publication No.: US10551381B2Publication Date: 2020-02-04
- Inventor: Irene Bosch , Kimberly Hamad-Schifferli , Jose Gomez-Marquez , Helena de Puig , Lee Gehrke
- Applicant: Massachusetts Institute of Technology
- Applicant Address: US MA Cambridge US MD Silver Springs
- Assignee: Massachusetts Institute of Technology,The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Current Assignee: Massachusetts Institute of Technology,The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Current Assignee Address: US MA Cambridge US MD Silver Springs
- Agency: Elmore Patent Law Group, P.C.
- Agent Darlene A. Vanstone; Carolyn S. Elmore
- Main IPC: C07K16/00
- IPC: C07K16/00 ; G01N33/569

Abstract:
The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject. The invention also provides kits comprising the matched antibody pairs of the invention and methods for using the kits for immunoassays for the specific detection of one or more serotypes of dengue virus in a patient population. The present invention also provides monoclonal antibodies specific for the NS1 protein of dengue virus and therapeutic compositions and methods for treating dengue virus infection.
Public/Granted literature
- US20170233460A1 Anti-Dengue Virus NS1 Protein Monoclonal Antibodies Public/Granted day:2017-08-17
Information query